Krystal Biotech, Inc. Employee Count
The employee counts Krystal Biotech, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 295; Filing 2026-02-17; Lease expense per employee $6,169.49.
- 2024-12-31: Employees (as filed) 275; Filing 2025-02-19; Lease expense per employee $5,181.82.
- 2023-12-31: Employees (as filed) 229; Filing 2024-02-26; Lease expense per employee $7,855.90.
- 2022-12-31: Employees (as filed) 210; Filing 2023-02-27; Lease expense per employee $8,371.43.
- Available history
- 2021-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 295 full-time | 2026-02-17 | $6,169.49 total lease cost |
| 2024-12-31 | 275 full-time | 2025-02-19 | $5,181.82 total lease cost |
| 2023-12-31 | 229 full-time | 2024-02-26 | $7,855.90 total lease cost |
| 2022-12-31 | 210 full-time | 2023-02-27 | $8,371.43 total lease cost |
| 2021-12-31 | 119 full-time | 2022-02-28 | $12,058.82 total lease cost |
Headcount breakdown as filed
| Fiscal year end | Employees | Xbrl:AwardType | Filing |
|---|---|---|---|
| 2017-12-31 | EmployeeStockOption: 0 | 2018-03-12 “” |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |